- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Medicamen Biotech has announced the publication of its unaudited financial results for the quarter ended June 30, 2025. These results were approved by the Board of Directors at their meeting on August 12. The company confirmed the newspaper publication, making these key financials accessible to investors. This update provides stakeholders with direct access to Medicamen's latest quarterly performance data, essential for understanding the company's recent operational and financial standing.